Orange County Bio’s Post

#ArticleoftheWeek published by #sciencedirect Organoids are transforming biomedical research: In a new study by Elisa Heinzelmann et al., induced pluripotent stem cell (iPSC) organoids are highly flexible but require a significant time investment to assemble. Patient-derived organoids are faster to create but show variability due to patient-specific traits. Both offer significant potential for drug discovery and personalized medicine. Automation is fast-tracking organoid technology toward clinical use— the next big medical breakthrough might just come from a lab dish! https://lnkd.in/e4bJC94B 🎉 Congratulations to: Elisa Heinzelmann, PhD, Francesco Piraino, PhD, Mariana Costa, Aline Roch, Maxim Norkin, Virginie Garnier, Krisztian Homicsko, Nathalie Brandenberg #Organoids #StemCells #Biotech #PersonalizedMedicine #DrugDiscovery #Incubator

🧬 Exciting news from the world of stem cell research! A recent study demonstrates how induced pluripotent stem cells (iPSCs) culture can be efficiently scaled up using microcarriers, achieving a higher expansion rate compared to traditional aggregate methods. 🌟 This innovative approach opens up new possibilities for advancing research and application in regenerative medicine, drug discovery, and beyond. 🚀 Interested in elevating your iPSCs culture to the next level? Get in touch with Smart MCs for cell-type specific and customised microcarrier solutions designed to optimize your research. 🌐 Let's innovate together for a healthier future! 💡 #StemCellResearch #iPSCs #RegenerativeMedicine #Biotechnology #Innovation #SmartMCs #ScienceandTechnology Read More: https://lnkd.in/gChqbDfE

Check out this thought-provoking article by Cameron Lee, Principal Scientist at Tune Therapeutics, now live on Drug Target Review. In this insightful piece, Dr Lee dives into the potential of epigenetics to harness the body’s natural regenerative capabilities. By leveraging the precise epigenetic control afforded by 'genetic tuning', stem cell-based therapies could transform how we treat chronic, degenerative, and age-related damage to human tissues and organs. Read the full piece here: https://lnkd.in/ePVevgte #Epigenetics #StemCellResearch #RegenerativeMedicine #Biotechnology #Innovation

In regenerative medicine applications, the success of cell expansion depends on three crucial factors: scalability, consistency, and preservation of stem cell differentiation potential. #StemCellResearch #RegenerativeMedicine #CellTherapySolutions

Who are the stem cell players that matter? ✨ Over the years the stem cell therapy market has gained traction and is valued at $12.4 billion in 2024 and is expected to reach $18.5 billion by 2029. With the increasing incidence of chronic and degenerative diseases, demand for stem cell treatment with reparative and regenerative properties is high. 🧬 The development of induced pluripotent stem cells and mesenchymal stem cells has allowed the creation of off-the-shelf cell therapies, more accessible and scalable. 📈 In this article, we delve into the companies to know about in this evolving field! ⬇️ https://lnkd.in/d2wD83QS #stemcelltherapy #regenerativemedicine #biotech #healthcareinnovation #chronicdiseases #degenerativediseases #celltherapy #biotechcompanies #stemcellresearch #medicalinnovation Aspen Neuroscience, Inc. | BlueRock Therapeutics | Cellino | Fate Therapeutics Inc. | Garuda Therapeutics | Mesoblast Limited | Orca Bio | Sana Biotechnology, Inc.

The global stem cells market is expected to grow at a robust rate of 9-12% for Forecasts 2023 to 2028. To learn more: https://lnkd.in/dJBKrb-h 🚀 This growth is driven by several factors: 🔹 Increasing prevalence of chronic diseases 🏥 🔹 Surge in research activities and favorable government support 🧬 🔹 Expanding clinical applications in regenerative medicine 🌿 🔹 Technological advancements in stem cell therapies 🔬 #StemCells #RegenerativeMedicine #Biotechnology #HealthTech #MedicalDevices #FutureOfHealthcare #Genomics #BioPharma

Join our November 6th webinar on automated solutions to enhance reproducibility and consistency in Induced Pluripotent Stem Cell (iPSC) research. Learn how the latest technologies can revolutionize stem cell culture, isolation, and expansion. Register now! CellCelector - Single Cell, Colony or Organoid Selection and Retrieval

👁️ 𝐅𝐢𝐫𝐬𝐭 𝐬𝐭𝐞𝐦 𝐜𝐞𝐥𝐥 𝐭𝐫𝐚𝐧𝐬𝐩𝐥𝐚𝐧𝐭 𝐫𝐞𝐬𝐭𝐨𝐫𝐞𝐬 𝐯𝐢𝐬𝐢𝐨𝐧 𝐢𝐧 𝐩𝐞𝐨𝐩𝐥𝐞 The study published in The Lancet described the case of four individuals with severely impaired vision due to limbal stem cell deficiency (LSCD) who received corneal transplants derived from reprogrammed stem cells.  The treatment developed at Osaka University in Japan used induced pluripotent stem (iPS) cells that were reprogrammed into corneal epithelial cells and grafted onto the damaged corneas. Two years post-treatment, patients have not experienced severe side effects or immune rejection. Very exiting! 𝐓𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐥𝐨𝐨𝐤𝐬 𝐛𝐫𝐢𝐠𝐡𝐭. #trials #ipscs #biotech #pharma #drjojo Source in the comments section ---------- Hi! I am Joanna, and my friends call me Dr Jojo 🌸 𝐈 𝐡𝐞𝐥𝐩 𝐬𝐭𝐚𝐫𝐭𝐮𝐩𝐬 𝐚𝐧𝐝 𝐞𝐧𝐭𝐫𝐞𝐩𝐫𝐞𝐧𝐞𝐮𝐫𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐭𝐡𝐞𝐢𝐫 𝐯𝐚𝐥𝐮𝐞 𝐚𝐧𝐝 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 ♻️ Share this if you find it interesting 🔔 Follow for insights you won't want to miss 📩 DM me to increase your visibility, grow your business, and generate leads

Well written article on factors and concepts which could influence how #stemcell activation and triggering could help treat #cancers. #oncology #cells

Unlocking Stem Cell Injections: The Future of Healing Discover the potential of stem cell injections and their transformative power in medicine. We explore how this innovative technology may become more accessible and its current limitations. Join us as we delve into the future of regenerative therapies! #StemCellTherapy #InnovativeMedicine #RegenerativeHealth #FutureOfHealing #MedicalBreakthroughs #HealthTechnology #SciTechExplained #HealingPotential #Biotechnology #PersonalizedMedicine X39patch.org